These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12484046

  • 21. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
    Montella L, Addeo R, Caraglia M, Faiola V, Guarrasi R, Vincenzi B, Palmeri A, Capasso E, Nocera V, Tarantino L, Ariete M, Martorelli A, Del Prete S.
    Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202
    [Abstract] [Full Text] [Related]

  • 22. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma.
    Arch-Ferrer JE, Smith JK, Bynon S, Eckhoff DE, Sellers MT, Bland KI, Heslin MJ.
    Am Surg; 2003 Dec; 69(12):1067-71. PubMed ID: 14700292
    [Abstract] [Full Text] [Related]

  • 23. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA.
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [Abstract] [Full Text] [Related]

  • 24. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
    Mahnken AH, Buecker A, Spuentrup E, Krombach GA, Henzler D, Günther RW, Tacke J.
    J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
    [Abstract] [Full Text] [Related]

  • 25. [Experience of radiofrequency ablation therapy for hepatocellular carcinoma].
    Iwauchi T, Yamada N, Amano R, Ohira M, Nishino H, Hirakawa K.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1663-5. PubMed ID: 16315902
    [Abstract] [Full Text] [Related]

  • 26. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
    Lam CM, Ng KK, Poon RT, Ai V, Yuen J, Fan ST.
    Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
    [Abstract] [Full Text] [Related]

  • 27. [Complete response (CR) in a case of advanced hepatocellular carcinoma by percutaneous multi-ablation therapy].
    Ishihara K, Beppu T, Ishiko T, Iwagami S, Doi K, Hirota M, Yamashita Y, Ogawa M.
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1791-4. PubMed ID: 11708036
    [Abstract] [Full Text] [Related]

  • 28. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.
    Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Funaki T, Arima K, Yoshida S, Nakai S, Murota M, Miyauchi Y, Kuriyama S.
    Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107
    [Abstract] [Full Text] [Related]

  • 29. Bleeding after percutaneous radiofrequency ablation: Successful treatment with transcatheter embolization.
    Carrafiello G, Laganà D, Ianniello A, Craparo G, Recaldini C, Lumia D, Dionigi G, Cuffari S, Fugazzola C.
    Eur J Radiol; 2007 Feb; 61(2):351-5. PubMed ID: 17097255
    [Abstract] [Full Text] [Related]

  • 30. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C.
    Hepatogastroenterology; 2003 Feb; 50(50):480-4. PubMed ID: 12749252
    [Abstract] [Full Text] [Related]

  • 31. Radiofrequency thermal ablation (RFA) of liver tumors: percutaneous and open surgical approaches.
    Crucitti A, Danza FM, Antinori A, Vincenzo A, Pirulli PG, Bock E, Magistrelli P.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):191-5. PubMed ID: 16767930
    [Abstract] [Full Text] [Related]

  • 32. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 33. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL, Wu SS, Obaid AK, French SW, Lois J, McMonigle M, Ramos HC, Sher LS, Lopez RR.
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of radiofrequency ablation therapy in patients with hepatic cavernous hemangiomas].
    Fan RF, Chai FL, He GX, Li RZ, Wan WX, Bai MD, Zhu WK, Cao ML, Li HM, Yan SZ.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 22; 85(23):1608-12. PubMed ID: 16185527
    [Abstract] [Full Text] [Related]

  • 35. [Radiofrequency ablation therapy combined with intrahepatic arterial infusion chemotherapy for liver metastasis of colorectal cancer].
    Otsuka S, Inagaki M, Miyoshi K, Takahashi M, Oosaki T, Fuchimoto S, Sakata T.
    Gan To Kagaku Ryoho; 2003 Oct 22; 30(11):1598-601. PubMed ID: 14619473
    [Abstract] [Full Text] [Related]

  • 36. [Radiofrequency ablation therapy combined with suture and ligation surgery for patients with giant cavernous hemangiomas of the liver].
    Fan RF, Chai FL, He GX, Wan WX, Bai MD, Cao ML, Li HM, Yan SZ.
    Zhonghua Yi Xue Za Zhi; 2006 Aug 15; 86(30):2134-7. PubMed ID: 17064621
    [Abstract] [Full Text] [Related]

  • 37. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT, Ng KK, Poon RT, Fan ST.
    J Hepatobiliary Pancreat Surg; 2009 Aug 15; 16(5):655-60. PubMed ID: 19370304
    [Abstract] [Full Text] [Related]

  • 38. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.
    Hepatogastroenterology; 2005 Aug 15; 52(65):1344-6. PubMed ID: 16201070
    [Abstract] [Full Text] [Related]

  • 39. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS, Zhang YJ, Li JQ, Liang HH, Zhang YQ, Zheng Y.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct 15; 27(10):623-5. PubMed ID: 16438875
    [Abstract] [Full Text] [Related]

  • 40. [Local ablation therapy for hepatocellular carcinoma (HCC) on the liver surface: radio-frequency ablation aimed at tumor marginal pre-ablation under endoscopic surgery].
    Ishiko T, Beppu T, Sugiyama S, Suyama K, Tashima R, Masuda T, Hirata A, Kanemitsu K, Egami H, Baba H.
    Gan To Kagaku Ryoho; 2005 Oct 15; 32(11):1657-9. PubMed ID: 16315900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.